Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.

Détails

Ressource 1Télécharger: 2021_JBCR.pdf (2584.35 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_2FE665354651
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Burn Center Organization and Cellular Therapy Integration: Managing Risks and Costs.
Périodique
Journal of burn care & research
Auteur⸱e⸱s
Chemali M., Laurent A., Scaletta C., Waselle L., Simon J.P., Michetti M., Brunet J.F., Flahaut M., Hirt-Burri N., Raffoul W., Applegate L.A., de Buys Roessingh A.S., Abdel-Sayed P.
ISSN
1559-0488 (Electronic)
ISSN-L
1559-047X
Statut éditorial
Publié
Date de publication
30/09/2021
Peer-reviewed
Oui
Volume
42
Numéro
5
Pages
911-924
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
The complex management of severe burn victims requires an integrative collaboration of multidisciplinary specialists in order to ensure quality and excellence in healthcare. This multidisciplinary care has quickly led to the integration of cell therapies in clinical care of burn patients. Specific advances in cellular therapy together with medical care have allowed for rapid treatment, shorter residence in hospitals and intensive care units, shorter durations of mechanical ventilation, lower complications and surgery interventions, and decreasing mortality rates. However, naturally fluctuating patient admission rates increase pressure toward optimized resource utilization. Besides, European translational developments of cellular therapies currently face potentially jeopardizing challenges on the policy front. The aim of the present work is to provide key considerations in burn care with focus on architectural and organizational aspects of burn centers, management of cellular therapy products, and guidelines in evolving restrictive regulations relative to standardized cell therapies. Thus, based on our experience, we present herein integrated management of risks and costs for preserving and optimizing clinical care and cellular therapies for patients in dire need.
Mots-clé
Burn Units/economics, Burn Units/organization & administration, Cell- and Tissue-Based Therapy/economics, Cell- and Tissue-Based Therapy/statistics & numerical data, Humans, Intensive Care Units/economics, Intensive Care Units/organization & administration, Patient Admission/economics
Pubmed
Web of science
Open Access
Oui
Financement(s)
Commission Européenne / H2020 / 833594
Création de la notice
14/05/2021 12:57
Dernière modification de la notice
21/02/2022 7:36
Données d'usage